Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (1530)	2/11/1999 9:07:00 PM
From: Pluvia	Respond to of 2135

<<<Steve, in this case I value the opinion of the NCI a great deal more than yours--and I think others will as well.>>> That's very wise, but... I think I'll stick with BMY, after all, this is their business and unlike the NCI, they are a "For Profit" business. BTW, Maybe you can point out where the NCI shows this ENMD "rat cure" compound can even be produced in a manner that would make it viable for use? You seem like a typical long who falls for the pretty blond (stock story), but never gets a date... I see you sleeping with her picture under your pillow. Dream on bud... History is full of promising agents that could not be produced economically. BMY bets this is one of them. My money is with BMY. Cheers Steve